...
首页> 外文期刊>American Journal of Cancer Research >Angiosarcoma: a review of diagnosis and current treatment
【24h】

Angiosarcoma: a review of diagnosis and current treatment

机译:Angiosarcoma:诊断和当前治疗综述

获取原文
           

摘要

Angiosarcoma is a highly malignancy of endothelial tumor and represents 1-2% of all soft tissue sarcomas in humans. The aetiology of angiosarcoma is not clear but there are definite risk factors including chronic lymphoedema, history of radiation, environmental carcinogens and certain familial syndromes. Ultrasound, CT and MR are diagnostic tools, but final diagnosis requires pathological and immunohistochemical confirmation. The conventional options of treatment include surgery, radiotherapy and chemotherapy. Targeted medicines and immunotherapy have been studied as promising treatment of angiosarcoma. The goal of this review is to summarize the current data regarding of angiosarcoma and its clinical presentation and management, providing a useful clinical tool to explore the optimal treatment.
机译:Agiosarcoma是内皮肿瘤的一种慢性恶性肿瘤,代表了人类中所有软组织肉瘤的1-2%。 Angiosarcoma的病因尚不清楚,但存在明确的风险因素,包括慢性淋巴水肿,辐射史,环境致癌物质和某些家族综合征。 超声波,CT和MR是诊断工具,但最终诊断需要病理和免疫组织化学确认。 常规治疗方案包括手术,放疗和化疗。 已经研究了有针对性的药物和免疫疗法作为有前途的昂贵arcoma治疗。 本综述的目标是总结当前关于临床介绍和管理的关于临床介绍和管理,提供有用的临床工具来探索最佳治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号